Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for SANUWAVE Health (SNWV) over the last 10 years, with Q3 2025 value amounting to $35.6 million.

  • SANUWAVE Health's Liabilities and Shareholders Equity rose 6296.92% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.6 million, marking a year-over-year increase of 4630.18%. This contributed to the annual value of $30.1 million for FY2024, which is 3436.38% up from last year.
  • SANUWAVE Health's Liabilities and Shareholders Equity amounted to $35.6 million in Q3 2025, which was up 6296.92% from $33.0 million recorded in Q2 2025.
  • SANUWAVE Health's Liabilities and Shareholders Equity's 5-year high stood at $35.6 million during Q3 2025, with a 5-year trough of $17.5 million in Q1 2023.
  • For the 3-year period, SANUWAVE Health's Liabilities and Shareholders Equity averaged around $25.0 million, with its median value being $22.4 million (2023).
  • As far as peak fluctuations go, SANUWAVE Health's Liabilities and Shareholders Equity soared by 738.37% in 2024, and later skyrocketed by 6296.92% in 2025.
  • Over the past 3 years, SANUWAVE Health's Liabilities and Shareholders Equity (Quarter) stood at $22.4 million in 2023, then surged by 34.36% to $30.1 million in 2024, then increased by 18.19% to $35.6 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $35.6 million for Q3 2025, versus $33.0 million for Q2 2025 and $30.9 million for Q1 2025.